{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:22:43Z","timestamp":1784211763414,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160615, 82360646"],"award-info":[{"award-number":["82160615, 82360646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160615, 82360646"],"award-info":[{"award-number":["82160615, 82360646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83924-0","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T02:29:29Z","timestamp":1735871369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Deep learning-based discovery of compounds for blood pressure lowering effects"],"prefix":"10.1038","volume":"15","author":[{"given":"Rongzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianchi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"83924_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.repc.2017.05.008","volume":"36","author":"AC Costa","year":"2017","unstructured":"Costa, A. C., Reina-Couto, M., Albino-Teixeira, A. & Sousa, T. Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs. Rev. Port Cardiol. 36, 551\u2013567. https:\/\/doi.org\/10.1016\/j.repc.2017.05.008 (2017).","journal-title":"Rev. Port Cardiol."},{"key":"83924_CR2","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1097\/ccm.0000000000000499","volume":"42","author":"SL Kane-Gill","year":"2014","unstructured":"Kane-Gill, S. L., LeBlanc, J. M., Dasta, J. F. & Devabhakthuni, S. A Multicenter study of the point prevalence of drug-induced hypotension in the ICU. Crit. Care Med. 42, 2197\u20132203. https:\/\/doi.org\/10.1097\/ccm.0000000000000499 (2014).","journal-title":"Crit. Care Med."},{"key":"83924_CR3","doi-asserted-by":"publisher","first-page":"704281","DOI":"10.3389\/fcvm.2021.704281","volume":"8","author":"A Calvi","year":"2021","unstructured":"Calvi, A. et al. Antidepressant drugs effects on blood pressure. Front. Cardiovasc. Med. 8, 704281. https:\/\/doi.org\/10.3389\/fcvm.2021.704281 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"83924_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bja.2021.10.044","volume":"128","author":"JR Sneyd","year":"2022","unstructured":"Sneyd, J. R., Absalom, A. R., Barends, C. R. M. & Jones, J. B. Hypotension during propofol sedation for colonoscopy: A retrospective exploratory analysis and meta-analysis. Br. J. Anaesth. 128, 610\u2013622. https:\/\/doi.org\/10.1016\/j.bja.2021.10.044 (2022).","journal-title":"Br. J. Anaesth."},{"key":"83924_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1345\/aph.1E496","volume":"39","author":"M Reed","year":"2005","unstructured":"Reed, M., Wall, G. C., Shah, N. P., Heun, J. M. & Hicklin, G. A. Verapamil toxicity resulting from a probable interaction with telithromycin. Ann. Pharmacother. 39, 357\u2013360. https:\/\/doi.org\/10.1345\/aph.1E496 (2005).","journal-title":"Ann. Pharmacother"},{"key":"83924_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s40266-022-00951-0","volume":"39","author":"G Bahat","year":"2022","unstructured":"Bahat, G. et al. Hypotension under Antihypertensive Treatment and Incident hospitalizations of nursing home residents. Drugs Aging. 39, 477\u2013484. https:\/\/doi.org\/10.1007\/s40266-022-00951-0 (2022).","journal-title":"Drugs Aging"},{"key":"83924_CR7","doi-asserted-by":"publisher","first-page":"117512","DOI":"10.1016\/j.lfs.2020.117512","volume":"249","author":"YC Loh","year":"2020","unstructured":"Loh, Y. C., Chan, S. Y., Tew, W. Y., Oo, C. W. & Yam, M. F. New flavonoid-based compound synthesis strategy for antihypertensive drug development. Life Sci. 249, 117512. https:\/\/doi.org\/10.1016\/j.lfs.2020.117512 (2020).","journal-title":"Life Sci."},{"key":"83924_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/s0140-6736(12)60825-3","volume":"380","author":"S Laurent","year":"2012","unstructured":"Laurent, S., Schlaich, M. & Esler, M. New drugs, procedures, and devices for hypertension. Lancet 380, 591\u2013600. https:\/\/doi.org\/10.1016\/s0140-6736(12)60825-3 (2012).","journal-title":"Lancet"},{"key":"83924_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","volume":"9","author":"RJ Yu","year":"2021","unstructured":"Yu, R. J., Krantz, M. S., Phillips, E. J. & Stone, C. A. Jr. Emerging causes of Drug-Induced anaphylaxis: a review of Anaphylaxis-Associated reports in the FDA adverse event reporting System (FAERS). J. Allergy Clin. Immunol. Pract. 9, 819\u2013829e812. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.021 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"83924_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","volume":"23","author":"H Chen","year":"2018","unstructured":"Chen, H., Engkvist, O., Wang, Y., Olivecrona, M. & Blaschke, T. The rise of deep learning in drug discovery. Drug Discov Today. 23, 1241\u20131250. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.039 (2018).","journal-title":"Drug Discov Today"},{"key":"83924_CR11","doi-asserted-by":"publisher","unstructured":"Nag, S. et al. Deep learning tools for advancing drug discovery and development. 3 Biotech. 12(110). https:\/\/doi.org\/10.1007\/s13205-022-03165-8 (2022).","DOI":"10.1007\/s13205-022-03165-8"},{"key":"83924_CR12","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/bib\/bby061","volume":"20","author":"AS Rifaioglu","year":"2019","unstructured":"Rifaioglu, A. S. et al. Recent applications of deep learning and machine intelligence on in silico drug discovery: Methods, tools and databases. Brief. Bioinform. 20, 1878\u20131912. https:\/\/doi.org\/10.1093\/bib\/bby061 (2019).","journal-title":"Brief. Bioinform"},{"key":"83924_CR13","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1038\/s41598-024-55205-3","volume":"14","author":"Q Dong","year":"2024","unstructured":"Dong, Q. et al. Novel antimicrobial peptides against Cutibacterium acnes designed by deep learning. Sci. Rep. 14, 4529. https:\/\/doi.org\/10.1038\/s41598-024-55205-3 (2024).","journal-title":"Sci. Rep."},{"key":"83924_CR14","doi-asserted-by":"publisher","first-page":"819046","DOI":"10.3389\/fmicb.2022.819046","volume":"13","author":"J Pi","year":"2022","unstructured":"Pi, J., Jiao, P., Zhang, Y. & Li, J. M. D. G. N. N. Microbial Drug Prediction based on heterogeneous multi-attention graph neural network. Front. Microbiol. 13, 819046. https:\/\/doi.org\/10.3389\/fmicb.2022.819046 (2022).","journal-title":"Front. Microbiol."},{"key":"83924_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41467-020-20213-0","volume":"12","author":"D Kusumoto","year":"2021","unstructured":"Kusumoto, D. et al. Anti-senescent drug screening by deep learning-based morphology senescence scoring. Nat. Commun. 12, 257. https:\/\/doi.org\/10.1038\/s41467-020-20213-0 (2021).","journal-title":"Nat. Commun."},{"key":"83924_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acs.jcim.3c01250","volume":"64","author":"E Heid","year":"2024","unstructured":"Heid, E. et al. Chemprop: A machine learning package for chemical property prediction. J. Chem. Inf. Model. 64, 9\u201317. https:\/\/doi.org\/10.1021\/acs.jcim.3c01250 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"83924_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello, S. M. et al. The drug repurposing hub: A next-generation drug library and information resource. Nat. Med. 23, 405\u2013408. https:\/\/doi.org\/10.1038\/nm.4306 (2017).","journal-title":"Nat. Med."},{"key":"83924_CR18","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15\u2013Ligand Discovery for everyone. J. Chem. Inf. Model. 55, 2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"83924_CR19","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688\u2013702e613. https:\/\/doi.org\/10.1016\/j.cell.2020.01.021 (2020).","journal-title":"Cell"},{"key":"83924_CR20","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil, B. et al. The ChEMBL Database in 2023: A drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 52, D1180\u2013D1192. https:\/\/doi.org\/10.1093\/nar\/gkad1004 (2024).","journal-title":"Nucleic Acids Res."},{"key":"83924_CR21","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.drudis.2019.07.006","volume":"24","author":"A Lavecchia","year":"2019","unstructured":"Lavecchia, A. Deep learning in drug discovery: Opportunities, challenges and future prospects. Drug Discov Today. 24, 2017\u20132032. https:\/\/doi.org\/10.1016\/j.drudis.2019.07.006 (2019).","journal-title":"Drug Discov Today"},{"key":"83924_CR22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/circresaha.121.318106","volume":"128","author":"S Padmanabhan","year":"2021","unstructured":"Padmanabhan, S., Tran, T. Q. B. & Dominiczak, A. F. Artificial Intelligence in Hypertension: Seeing through a Glass darkly. Circ. Res. 128, 1100\u20131118. https:\/\/doi.org\/10.1161\/circresaha.121.318106 (2021).","journal-title":"Circ. Res."},{"key":"83924_CR23","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim, S. et al. PubChem in 2021: New data content and improved web interfaces. Nucleic Acids Res. 49, D1388\u2013d1395. https:\/\/doi.org\/10.1093\/nar\/gkaa971 (2021).","journal-title":"Nucleic Acids Res."},{"key":"83924_CR24","doi-asserted-by":"publisher","first-page":"34160","DOI":"10.1021\/acsomega.3c05425","volume":"8","author":"M Yasir","year":"2023","unstructured":"Yasir, M. et al. Vismodegib identified as a novel COX-2 inhibitor via deep-learning-based drug repositioning and molecular docking analysis. ACS Omega. 8, 34160\u201334170. https:\/\/doi.org\/10.1021\/acsomega.3c05425 (2023).","journal-title":"ACS Omega"},{"key":"83924_CR25","doi-asserted-by":"publisher","unstructured":"Cheng, Y., Gong, Y., Liu, Y., Song, B. & Zou, Q. Molecular design in drug discovery: A comprehensive review of deep generative models. Brief. Bioinform. 22 https:\/\/doi.org\/10.1093\/bib\/bbab344 (2021).","DOI":"10.1093\/bib\/bbab344"},{"key":"83924_CR26","doi-asserted-by":"publisher","first-page":"113978","DOI":"10.1016\/j.ab.2020.113978","volume":"610","author":"SM Hasan Mahmud","year":"2020","unstructured":"Hasan Mahmud, S. M. et al. DeepACTION: A deep learning-based method for predicting novel drug-target interactions. Anal. Biochem. 610, 113978. https:\/\/doi.org\/10.1016\/j.ab.2020.113978 (2020).","journal-title":"Anal. Biochem."},{"key":"83924_CR27","doi-asserted-by":"publisher","unstructured":"Sarkar, C. et al. Artificial intelligence and machine learning technology driven modern drug discovery and development. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24032026 (2023).","DOI":"10.3390\/ijms24032026"},{"key":"83924_CR28","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s11030-021-10256-w","volume":"25","author":"MK Tripathi","year":"2021","unstructured":"Tripathi, M. K., Nath, A., Singh, T. P., Ethayathulla, A. S. & Kaur, P. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. Mol. Divers. 25, 1439\u20131460. https:\/\/doi.org\/10.1007\/s11030-021-10256-w (2021).","journal-title":"Mol. Divers."},{"key":"83924_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/omi.2019.0151","volume":"23","author":"M Koromina","year":"2019","unstructured":"Koromina, M., Pandi, M. T. & Patrinos, G. P. Rethinking drug repositioning and development with Artificial Intelligence, Machine Learning, and Omics. Omics 23, 539\u2013548. https:\/\/doi.org\/10.1089\/omi.2019.0151 (2019).","journal-title":"Omics"},{"key":"83924_CR30","doi-asserted-by":"publisher","first-page":"562677","DOI":"10.3389\/fbioe.2020.562677","volume":"8","author":"T Li","year":"2020","unstructured":"Li, T., Tong, W., Roberts, R., Liu, Z. & Thakkar, S. Deep learning on high-throughput transcriptomics to predict drug-induced liver injury. Front. Bioeng. Biotechnol. 8, 562677. https:\/\/doi.org\/10.3389\/fbioe.2020.562677 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"83924_CR31","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51, D1373\u2013D1380. https:\/\/doi.org\/10.1093\/nar\/gkac956 (2023).","journal-title":"Nucleic Acids Res."},{"key":"83924_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-0716-2305-3_7","volume":"2496","author":"B Bhasuran","year":"2022","unstructured":"Bhasuran, B. Combining literature mining and machine learning for predicting biomedical discoveries. Methods Mol. Biol. 2496, 123\u2013140. https:\/\/doi.org\/10.1007\/978-1-0716-2305-3_7 (2022).","journal-title":"Methods Mol. Biol."},{"key":"83924_CR33","doi-asserted-by":"publisher","unstructured":"Pinzi, L. & Rastelli, G. Molecular Docking: Shifting paradigms in Drug Discovery. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20184331 (2019).","DOI":"10.3390\/ijms20184331"},{"key":"83924_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13321-023-00721-z","volume":"15","author":"N Schaduangrat","year":"2023","unstructured":"Schaduangrat, N., Anuwongcharoen, N., Charoenkwan, P. & Shoombuatong, W. DeepAR: A novel deep learning-based hybrid framework for the interpretable prediction of androgen receptor antagonists. J. Cheminform. 15, 50. https:\/\/doi.org\/10.1186\/s13321-023-00721-z (2023).","journal-title":"J. Cheminform"},{"key":"83924_CR35","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1039\/d2md00112h","volume":"13","author":"AM Chan","year":"2022","unstructured":"Chan, A. M., Goodis, C. C., Pommier, E. G. & Fletcher, S. Recent applications of covalent chemistries in protein-protein interaction inhibitors. RSC Med. Chem. 13, 921\u2013928. https:\/\/doi.org\/10.1039\/d2md00112h (2022).","journal-title":"RSC Med. Chem."},{"key":"83924_CR36","doi-asserted-by":"publisher","unstructured":"Chang, Z. et al. Therapeutic targets and mechanism of Xingpi Jieyu Decoction in Depression: A Network Pharmacology Study. Evid. Based Complement. Alternat Med. 2021(5516525). https:\/\/doi.org\/10.1155\/2021\/5516525 (2021).","DOI":"10.1155\/2021\/5516525"},{"key":"83924_CR37","doi-asserted-by":"publisher","unstructured":"Caballero, J. Considerations for docking of selective angiotensin-converting enzyme inhibitors. Molecules 25 https:\/\/doi.org\/10.3390\/molecules25020295 (2020).","DOI":"10.3390\/molecules25020295"},{"key":"83924_CR38","doi-asserted-by":"publisher","unstructured":"Ciftci, M. H., Turkoglu, V., Bas, Z. & Celikezen, F. C. In vitro inhibitor effect and molecular docking of thiamine (vitamin B(1)), riboflavin (vitamin B(2)), and reference inhibitor captopril on angiotensin-converting enzyme purified from sheep plasma. Arch. Physiol. Biochem. 1\u201310. https:\/\/doi.org\/10.1080\/13813455.2024.2376814 (2024).","DOI":"10.1080\/13813455.2024.2376814"},{"key":"83924_CR39","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/febs.14421","volume":"285","author":"GE Cozier","year":"2018","unstructured":"Cozier, G. E. et al. Crystal structures of sampatrilat and sampatrilat-asp in complex with human ACE - a molecular basis for domain selectivity. Febs j. 285, 1477\u20131490. https:\/\/doi.org\/10.1111\/febs.14421 (2018).","journal-title":"Febs j."},{"key":"83924_CR40","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1111\/febs.15601","volume":"288","author":"GE Cozier","year":"2021","unstructured":"Cozier, G. E., Lubbe, L., Sturrock, E. D. & Acharya, K. R. Angiotensin-converting enzyme open for business: structural insights into the subdomain dynamics. Febs j. 288, 2238\u20132256. https:\/\/doi.org\/10.1111\/febs.15601 (2021).","journal-title":"Febs j."},{"key":"83924_CR41","doi-asserted-by":"publisher","unstructured":"Zheng, Y. et al. Isolation of Novel ACE-Inhibitory and antioxidant peptides from Quinoa Bran Albumin assisted with an in Silico Approach: characterization, in vivo antihypertension, and Molecular Docking. Molecules 24 https:\/\/doi.org\/10.3390\/molecules24244562 (2019).","DOI":"10.3390\/molecules24244562"},{"key":"83924_CR42","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","volume":"28","author":"A Volkamer","year":"2012","unstructured":"Volkamer, A., Kuhn, D., Rippmann, F. & Rarey, M. DoGSiteScorer: A web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics 28, 2074\u20132075. https:\/\/doi.org\/10.1093\/bioinformatics\/bts310 (2012).","journal-title":"Bioinformatics"},{"key":"83924_CR43","doi-asserted-by":"publisher","unstructured":"Chamata, Y., Watson, K. A. & Jauregi, P. Whey-derived peptides interactions with ACE by molecular docking as a potential Predictive Tool of Natural ACE inhibitors. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21030864 (2020).","DOI":"10.3390\/ijms21030864"},{"key":"83924_CR44","doi-asserted-by":"publisher","unstructured":"Lin, S. R., Lin, S. Y., Chen, C. C., Fu, Y. S. & Weng, C. F. Exploring a New Natural Treating Agent for primary hypertension: Recent findings and forthcoming perspectives. J. Clin. Med. 8 https:\/\/doi.org\/10.3390\/jcm8112003 (2019).","DOI":"10.3390\/jcm8112003"},{"key":"83924_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11130-023-01074-6","volume":"78","author":"J Li","year":"2023","unstructured":"Li, J., Huo, X., Zheng, Y., Guo, Y. & Feng, C. ACE-Inhibitory peptides identified from Quinoa Bran Glutelin-2 hydrolysates: In Silico Screening and characterization, inhibition mechanisms of ACE, coordination with zinc ions, and Stability. Plant. Foods Hum. Nutr. 78, 419\u2013425. https:\/\/doi.org\/10.1007\/s11130-023-01074-6 (2023).","journal-title":"Plant. Foods Hum. Nutr."},{"key":"83924_CR46","doi-asserted-by":"publisher","unstructured":"Aziz, M. et al. Deep learning and structure-based virtual screening for Drug Discovery against NEK7: A Novel Target for the treatment of Cancer. Molecules 27 https:\/\/doi.org\/10.3390\/molecules27134098 (2022).","DOI":"10.3390\/molecules27134098"},{"key":"83924_CR47","doi-asserted-by":"publisher","first-page":"17124","DOI":"10.1021\/acs.jmedchem.4c00656","volume":"67","author":"W Deng","year":"2024","unstructured":"Deng, W. et al. Peptidomimetic Analogues Act as effective inhibitors against SARS-CoV-2 by blocking the function of Cathepsin L. J. Med. Chem. 67, 17124\u201317143. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00656 (2024).","journal-title":"J. Med. Chem."},{"key":"83924_CR48","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/0006-2952(91)90509-4","volume":"42","author":"K Weisser","year":"1991","unstructured":"Weisser, K. & Schloos, J. The role of enzyme and substrate concentration in the evaluation of serum angiotensin converting enzyme (ACE) inhibition by enalaprilat in vitro. Biochem. Pharmacol. 42, 1729\u20131737. https:\/\/doi.org\/10.1016\/0006-2952(91)90509-4 (1991).","journal-title":"Biochem. Pharmacol."},{"key":"83924_CR49","doi-asserted-by":"publisher","unstructured":"Vogt, M. & Bajorath, J. Modeling Tanimoto Similarity Value distributions and Predicting Search results. Mol. Inf. 36 https:\/\/doi.org\/10.1002\/minf.201600131 (2017).","DOI":"10.1002\/minf.201600131"},{"key":"83924_CR50","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/1573409915666190528114703","volume":"16","author":"S M","year":"2020","unstructured":"M, S., Swaminathan, P. & B, P. & An in silico Workflow that yields experimentally comparable inhibitors for human dihydroorotate dehydrogenase. Curr. Comput. Aided Drug Des. 16, 340\u2013350. https:\/\/doi.org\/10.2174\/1573409915666190528114703 (2020).","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"83924_CR51","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1080\/07391102.2020.1827038","volume":"40","author":"K Sahin","year":"2022","unstructured":"Sahin, K. In silico identification of angiotensin-1 converting enzyme inhibitors using text mining and virtual screening. J. Biomol. Struct. Dyn. 40, 1152\u20131162. https:\/\/doi.org\/10.1080\/07391102.2020.1827038 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"83924_CR52","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.2174\/1381612826666200515131245","volume":"26","author":"A Thakur","year":"2020","unstructured":"Thakur, A. et al. Application of Artificial Intelligence in Pharmaceutical and Biomedical studies. Curr. Pharm. Des. 26, 3569\u20133578. https:\/\/doi.org\/10.2174\/1381612826666200515131245 (2020).","journal-title":"Curr. Pharm. Des."},{"key":"83924_CR53","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/bib\/bbaa040","volume":"22","author":"CY Lee","year":"2021","unstructured":"Lee, C. Y. & Chen, Y. P. Prediction of drug adverse events using deep learning in pharmaceutical discovery. Brief. Bioinform. 22, 1884\u20131901. https:\/\/doi.org\/10.1093\/bib\/bbaa040 (2021).","journal-title":"Brief. Bioinform"},{"key":"83924_CR54","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fmolb.2020.00132","volume":"7","author":"V Spiwok","year":"2020","unstructured":"Spiwok, V. & K\u0159\u00ed\u017e, P. Time-lagged t-Distributed Stochastic Neighbor Embedding (t-SNE) of Molecular Simulation trajectories. Front. Mol. Biosci. 7, 132. https:\/\/doi.org\/10.3389\/fmolb.2020.00132 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"83924_CR55","doi-asserted-by":"publisher","unstructured":"Wang, X., Jin, Y., Schmitt, S. & Olhofer, M. Recent advances in bayesian optimization. ACM Comput. Surv. 55, Article 287, https:\/\/doi.org\/10.1145\/3582078 (2023).","DOI":"10.1145\/3582078"},{"key":"83924_CR56","doi-asserted-by":"publisher","first-page":"22994","DOI":"10.1038\/s41598-023-50393-w","volume":"13","author":"N Schaduangrat","year":"2023","unstructured":"Schaduangrat, N., Homdee, N. & Shoombuatong, W. StackER: A novel SMILES-based stacked approach for the accelerated and efficient discovery of ER\u03b1 and ER\u03b2 antagonists. Sci. Rep. 13, 22994. https:\/\/doi.org\/10.1038\/s41598-023-50393-w (2023).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83924-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T19:04:47Z","timestamp":1735931087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83924-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83924"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83924-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Animal Ethics Commit-tee of Guilin Medical University, and the number is GLMC202103003. The study is reported in accordance with ARRIVE guidelines ().","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"54"}}